Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Effectiveness and Safety of the Ulthera® System for Skin Laxity in the Lower Face, Submentum and Neck

NCT: NCT07614997 · NOT_YET_RECRUITING

NCT IDNCT07614997
StatusNOT_YET_RECRUITING
Start Date2026-06
Completion2027-03

Brief Summary

The purpose of this study is to demonstrate superiority of treatment with the Ulthera System compared to untreated control for the improvement of skin laxity of the lower face, submental area and neck and to demonstrate the safety of treatment with the Ulthera System for the improvement of skin laxity of the lower face, submental area and neck.

Frequently Asked Questions

What is Effectiveness and Safety of the Ulthera® System for Skin Laxity in the Lower Face, Submentum and Neck?

Effectiveness and Safety of the Ulthera® System for Skin Laxity in the Lower Face, Submentum and Neck is a clinical trial registered under NCT07614997. Current status: NOT_YET_RECRUITING.

What is the status of NCT07614997?

The current status of NCT07614997 (Effectiveness and Safety of the Ulthera® System for Skin Laxity in the Lower Face, Submentum and Neck) is: NOT_YET_RECRUITING.

When did Effectiveness and Safety of the Ulthera® System for Skin Laxity in the Lower Face, Submentum and Neck start?

Effectiveness and Safety of the Ulthera® System for Skin Laxity in the Lower Face, Submentum and Neck started on 2026-06.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑